Home
Photo of Thomas Schön

Thomas Schön

Professor

My research concerns individualized treatment and improved diagnostics for tuberculosis and other infectious diseases.

Research focused on tuberculosis

My research is mainly focused on tuberculosis which causes about 10 million new cases per year of which about 1 million die. The immune system, bacterial resistance mechanisms to treatment and antibiotic dosing are important factors that partly determine who gets sick and who does not, but also how successful the treatment will be.

Several of my research projects in both Sweden and Ethiopia concern individualized treatment and improved diagnostics for tuberculosis and other infectious diseases, with the aim of improving the resilience of the immune system and streamlining treatment.

News

vaccination.

SEK 15 million for research into Covid-19 vaccination

A research project coordinated by LiU has been awarded more than SEK 15 million by the Swedish Research Council to evaluate vaccination against Covid-19.

Publications

Latest publications in LiU DiVA

2026

Katarina Niward, Clara Braian, Gustav Svärdhagen, Daniel Augustinsson, Isabelle Öhrnberg, Rovina Ruslami, Stellah Mpagama, Elin M. Svensson, Judith Bruchfeld, Jan-Willem Alffenaar, Thomas Schön (2026) Future Prospects for Using Clinical Phenotypes in Tuberculosis Precision Medicine-An Approach for Clinical Management Clinical Infectious Diseases, Article PMID 9203213 (Article, review/survey) Continue to DOI

2025

Praharshinie Rupasinghe, Nabila Ismail, Wim Mulders, Robin M. Warren, Lavania Joseph, Dumisani Ngcamu, Thabisile Gwala, Shaheed V. Omar, Jens Vereecken, Bouke C. de Jong, Leen Rigouts, Emanuele Borroni, Daniela M. Cirillo, Thomas Schön, Paolo Miotto, Claudio U. Koser (2025) In vitro exposure to clofazimine can select for delamanid and pretomanid resistance in Mycobacterium tuberculosis Antimicrobial Agents and Chemotherapy (Article in journal) Continue to DOI
Thomas Schön, Paolo Miotto, Varvara K. Kozyreva, Matthew D. Sylvester, Daniela M. Cirillo, Claudio U. Koser (2025) Quality control and considering systematic MIC shifts are key when evaluating the role of mmpR5 (Rv0678) frameshifts in bedaquiline resistance Antimicrobial Agents and Chemotherapy (Article in journal) Continue to DOI
Trinh Thi Trang Nhung, Swati Verma, Saravanaraman Ponne, Gautam Kumar Meghwanshi, Thomas Schön, Rajender Kumar (2025) Bacteriophage-based strategies for biocontrol and treatment of infectious diseases Computational and Structural Biotechnology Journal, Vol. 27, p. 2924-2932 (Article, review/survey) Continue to DOI
John Walles, Niclas Winqvist, Stefan R. Hansson, Erik Sturegard, Haitham Baqir, Torbjorn Kjerstadius, Thomas Schön, Per Bjorkman (2025) Association between plasma interferon-? levels and preeclampsia in pregnant women screened for tuberculosis infection Clinical Microbiology and Infection, Vol. 31, p. 1394-1397 (Article in journal) Continue to DOI

Research

A doctor looks at X-rays.

Individualised diagnosis and treatment of tuberculosis

Our general aim is to individualise and thereby optimize management of clinical TB by new methods and strategies. The research group consists of specialists in tuberculosis from different professions.

Organisation

Teaser image for the division II at BKV.

Division of Inflammation and Infection (II)

The Division of Inflammation and Infection (II) includes clinical subject areas such as Immunology, Rheumatology, Pathology and Microbiology.

Department of Biomedical and Clinical Sciences (BKV)

What characterizes the Department of Biomedical and Clinical Sciences (BKV) is the wide breadth of research and education. BKV is one of the largest departments at LiU with affiliation mainly to the Faculty of Medicine and Health Sciences.

Tags